1-1 of 1
Kevin J. Curran
Close
Sort by
Journal Articles

Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen

Renier J. Brentjens, Kevin J. Curran
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 143–151.
https://doi.org/10.1182/asheducation.V2012.1.143.3798224
Published: 2012